Showing results (11-20 of 463) with videos related to
Sort By:
Pageof 47
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 9, 2017
Tumor Vaccines for Malignant GliomasVisish M Srinivasan, Sherise D Ferguson, Sungho Lee, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 3, 2022
Financial distress and its associated burden in couples coping with an advanced cancerJuliet L Kroll, Seokhun Kim, Dalnim Cho, et al.Journal of Immunotherapy and Precision Oncology|November 18, 2024
Diaphragmatic Myopathy Associated with Dual Immune Checkpoint Inhibitors in a Patient with Renal Cell CarcinomaJeremy R Walder, Saadia A Faiz, Sudhakar Tummala, et al.NPJ Precision Oncology|May 25, 2023
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastomaBlessie Elizabeth Nelson, Neha K Reddy, Jason T Huse, et al.Neuro-Oncology Practice|July 15, 2024
Simulation-based caregiving skills training for family members of high-grade glioma patientsMeagan Whisenant, Shiao-Pei Weathers, Yisheng Li, et al.Journal of Neuro-Oncology|July 14, 2016
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastomaShiao-Pei Weathers, Xiaosi Han, Diane D Liu, et al.Oncotarget|November 20, 2019
Pre-surgical connectome features predict IDH status in diffuse gliomasShelli R Kesler, Rebecca A Harrison, Melissa L Petersen, et al.Cold Spring Harbor Molecular Case Studies|August 27, 2020
Dual inhibition of BRAF and mTOR in BRAF -mutant pediatric, adolescent, and young adult brain tumorsShiraj Sen, Ryuma Tanaka, Soumen Khatua, et al.Seminars in Oncology|November 15, 2011
Recurrent glioblastoma: a fresh look at current therapies and emerging novel approachesMark R GilbertCurrent Oncology Reports|February 9, 2006
Advances in the treatment of primary brain tumors: dawn of a new era?Mark R GilbertPageof 47